Edition:
United Kingdom

Medivir AB (MVIRb.ST)

MVIRb.ST on Stockholm Stock Exchange

35.75SEK
5:00pm BST
Change (% chg)

-0.15kr (-0.42%)
Prev Close
35.90kr
Open
35.45kr
Day's High
35.95kr
Day's Low
35.35kr
Volume
20,250
Avg. Vol
46,299
52-wk High
81.75kr
52-wk Low
32.10kr

Chart for

About

Medivir AB is a Sweden-based pharmaceutical company engaged in the research, development and sale of drugs against widespread diseases, with protease and polymerase as its target enzymes. The Company’s research focuses on developing small molecule pharmaceuticals, primarily against infectious diseases caused by viruses. The... (more)

Overall

Beta: 1.15
Market Cap(Mil.): kr1,394.06
Shares Outstanding(Mil.): 19.84
Dividend: --
Yield (%): --

Financials

  MVIRb.ST Industry Sector
P/E (TTM): -- 85.68 32.76
EPS (TTM): -14.03 -- --
ROI: -33.02 1.78 14.61
ROE: -34.12 3.28 16.33

BRIEF-Medivir Q1 operating loss narrows

* MEDIVIR Q1 NET TURNOVER TOTALED SEK 4.5 MILLION (17.8 M)OF WHICH SEK 4.5 MILLION (13.7 M) COMPRISED THE FIRST QUARTER’S ROYALTIES

27 Apr 2018

Earnings vs. Estimates